Hepatobiliary Pancreat Dis Int
October 2024
Hepatobiliary Pancreat Dis Int
June 2024
Hepatobiliary Pancreat Dis Int
October 2021
Background: Pancreatic cancer is one of the most aggressive malignancies and chemotherapy is an effective strategy for advanced pancreatic cancer. Gemcitabine (GEM) is one of first-line agents. However, GEM-based combination therapy has shown promising efficacy in patients with advanced pancreatic cancer.
View Article and Find Full Text PDFHepatobiliary Pancreat Dis Int
October 2012
Background: Ischemia/reperfusion (I/R) injury is an important barrier to liver surgery and transplantation because it impairs remnant liver/reduced-size-graft regeneration. Ischemic preconditioning (IPC), as an effective measure to overcome I/R injury, has been shown to enhance the regenerative capacity of hepatocytes. However, investigations have always focused on regeneration in the late phase after reperfusion.
View Article and Find Full Text PDF